Boots sells Farley's baby foods: Deal with Heinz helps company's core products strategy
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.BOOTS has agreed to sell its Farley's baby food and adult nutrition businesses to H J Heinz for pounds 94m. The sale is intended to allow Boots Healthcare International, the consumer healthcare products arm, to concentrate on its core over-the-counter medicines.
The disposal follows smaller sales of brands outside the product categories Boots wants to develop - cough and cold remedies, pain relief, eye care and skin care.
It has recently made acquisitions in France and Italy complementing these areas. Mike Gates, a company spokesman, said Boots intended to develop the four core categories into pan-European businesses.
Boots will have no nutrition businesses left after the sale. It said it did not expect to make further healthcare disposals.
It launched a review of its prescription drugs division after the withdrawal last July of Manoplax, a heart drug, dealt a serious blow to its ambitions in pharmaceuticals. Mr Gates said a full or partial disposal of the pharmaceuticals arm was still under consideration.
Products being taken over by Heinz, including Farley's rusks, Timers baby cereals and Crunch 'n' Slim diet foods, had sales of pounds 53m in the year to 31 March, 70 per cent in Britain. Net assets of pounds 21m are included in the sale.
Heinz made the initial approach. Andrew Barrett, UK managing director, said the acquisition would help Heinz towards its goal of being a leading European baby food manufacturer.
Boots will publish the profits of the businesses and the balance sheet effects of the sale with its annual results on Thursday. The shares fell 15p to 509p.
(Photograph omitted)
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments